A Perspective on the Comparative Antileukemic Activity of 5-Aza-2′-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)

5-Aza-2′-deoxycytidine (5-AZA-CdR, decitabine, Dacogen®) and 5-azacytidine (5-AC, Vidaza®) are epigenetic agents that have been approved for the clinical treatment of the hematological malignancy myelodysplastic syndrome (MDS) and are currently under clinical evaluation for the treatment of acute my...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autor: Momparler, Richard L.
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2012
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3763670/
https://ncbi.nlm.nih.gov/pubmed/24280679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph5080875
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky